Moderna has announced a 94.5% efficacy rate for their V*.
Their analysis was based on 95 cases, of which 90 cases of COVID-19 were observed in the placebo group versus 5 cases observed in the V* group, resulting in a V* efficacy of 94.5%.
It is important to note, we are only looking at 95 participants out of approximately 30,000. This would also mean that the placebo is about as effective as the V*. (99.994% efficacy vs. 99.9997% efficacy in the V* group.)
Become empowered and knowledgable on these high profile Va((ines by signing up to read our guide, "Everything You Need to Know about the COVID-19 Va((ine." Link in Bio.
https://researchbased.co/covid-19-vaccine-report
Sources:
https://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy
Their analysis was based on 95 cases, of which 90 cases of COVID-19 were observed in the placebo group versus 5 cases observed in the V* group, resulting in a V* efficacy of 94.5%.
It is important to note, we are only looking at 95 participants out of approximately 30,000. This would also mean that the placebo is about as effective as the V*. (99.994% efficacy vs. 99.9997% efficacy in the V* group.)
Become empowered and knowledgable on these high profile Va((ines by signing up to read our guide, "Everything You Need to Know about the COVID-19 Va((ine." Link in Bio.
https://researchbased.co/covid-19-vaccine-report
Sources:
https://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy